Adipocyte-derived PDGF-D counteracts age-associated obesity through ameliorating lymphatic function
- 1Department of Cardiovascular Medicine, Shanghai Institute of Hypertension, National Center for Translational Medicine·Shanghai, State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- 2Department of Cardiology, Huadong Hospital Affiliated to Fudan University
Abstract
Normal lymphatic function protects against obesity by preventing abnormal lymph leakage, which drives excessive adipocyte proliferation in adjacent tissues. Notably, platelet-derived growth factor D (PDGF-D) has been reported to play key roles in lymphangiogenesis. However, whether PDGF-D regulates age-associated obesity through modulation of lymphatic function remains unknown. In the study, we found that middle-aged mice exhibited greater susceptibility to high-fat diet (HFD)-induced obesity than young mice, accompanied by reduced lymphatic vessel density, impaired lymphatic function, and decreased PDGF-D expression in adipose tissue. By generating adipocyte-specific PDGF-D knockout and overexpression mice, we demonstrated that PDGF-D deficiency, despite having no direct effect on adipocytes, was sufficient to induce lymphatic dysfunction, which in turn exacerbated HFD-induced obesity in young mice. While adipocyte-specific PDGF-D overexpression restored lymphatic function and reversed HFD-induced severe obesity in middle-aged mice. Moreover, stimulating lymphangiogenesis via adeno-associated virus (AAV)-mediated delivery of an engineered VEGF-C variant (VEGF-C156S) successfully suppressed HFD-induced obesity in young adipocyte-PDGF-D knockout mice. In vitro , we found that adipocyte-derived PDGF-D promoted tube formation, proliferation, and the integrity of lymphatic endothelial cells (LECs), thereby preventing lipid permeation and subsequently suppressing adipogenesis. In conclusion, these findings demonstrate an uncovered mechanism by which adipocyte-derived PDGF-D protects against age-related obesity through regulation of lymphatic function.
Related
- Cholesterol-Mediated Modulation of Collecting Lymphatic Vessel Contractility: Exploring Cholesterol Depletion as a Therapeutic Alternative to Improve Lymphatic Function in Hypercholesterolemia
- Targeting Obesity-Associated Breast Cancer: Curcumin Counteracts Leptin-Induced Tumorigenic and Metastatic Traits in MCF-7 and MDA-MB-231 Breast Cancer Cells.
- Lymphatic Preconditioning for Preservation of Lymphatic Function
- Serum indocyanine green quantification enables objective assessment of lymphatic function
- Adma and Ackr3a regulate cardiac lymphatic vessel formation and function during heart development and regeneration
BibTeX
@article{xu2026adipocytederived,
title = {{Adipocyte-derived PDGF-D counteracts age-associated obesity through ameliorating lymphatic function}},
author = {Lian Xu and Yuwen Cheng and Jiaqi Li and Yonghua Zhai and Jingrong Lin and Zebei Zhang},
journal = {Frontiers in Endocrinology},
year = {2026},
month = nov,
doi = {10.3389/fendo.2026.1963378},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1963378/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Adipocyte-derived PDGF-D counteracts age-associated obesity through ameliorating lymphatic function
AU - Lian Xu
AU - Yuwen Cheng
AU - Jiaqi Li
AU - Yonghua Zhai
AU - Jingrong Lin
AU - Zebei Zhang
PY - 2026
DA - 2026/11/04
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1963378
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1963378/full
AB - Normal lymphatic function protects against obesity by preventing abnormal lymph leakage, which drives excessive adipocyte proliferation in adjacent tissues. Notably, platelet-derived growth factor D (PDGF-D) has been reported to play key roles in lymphangiogenesis. However, whether PDGF-D regulates age-associated obesity through modulation of lymphatic function remains unknown. In the study, we found that middle-aged mice exhibited greater susceptibility to high-fat diet (HFD)-induced obesity than young mice, accompanied by reduced lymphatic vessel density, impaired lymphatic function, and decreased PDGF-D expression in adipose tissue. By generating adipocyte-specific PDGF-D knockout and overexpression mice, we demonstrated that PDGF-D deficiency, despite having no direct effect on adipocytes, was sufficient to induce lymphatic dysfunction, which in turn exacerbated HFD-induced obesity in young mice. While adipocyte-specific PDGF-D overexpression restored lymphatic function and reversed HFD-induced severe obesity in middle-aged mice. Moreover, stimulating lymphangiogenesis via adeno-associated virus (AAV)-mediated delivery of an engineered VEGF-C variant (VEGF-C156S) successfully suppressed HFD-induced obesity in young adipocyte-PDGF-D knockout mice. In vitro , we found that adipocyte-derived PDGF-D promoted tube formation, proliferation, and the integrity of lymphatic endothelial cells (LECs), thereby preventing lipid permeation and subsequently suppressing adipogenesis. In conclusion, these findings demonstrate an uncovered mechanism by which adipocyte-derived PDGF-D protects against age-related obesity through regulation of lymphatic function.
SN - 1664-2392
ER -